Are you Dr. Reinherz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana Farber Cancer Inst.
44 Binney Street
Boston, MA 02115Phone+1 617-632-3412
Summary
- Dr. Ellis Reinherz, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
Harvard Medical SchoolClass of 1975
Certifications & Licensure
MA State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Load-based divergence in the dynamic allostery of two TCRs recognizing the same pMHC.Ana C Chang-Gonzalez, Aoi Akitsu, Robert J Mallis, Matthew J Lang, Ellis L Reinherz
Biorxiv. 2025-03-03 - Biophysical and Structural Features of αβT-Cell Receptor Mechanosensing: A Paradigmatic Shift in Understanding T-Cell Activation.Robert J Mallis, Kristine N Brazin, Jonathan S Duke-Cohan, Aoi Akitsu, Hanna M Stephens
Immunological Reviews. 2025-01-01 - 4 citationsParsing digital or analog TCR performance through piconewton forces.Aoi Akitsu, Eiji Kobayashi, Yinnian Feng, Hannah M Stephens, Kristine N Brazin
Science Advances. 2024-08-16
Press Mentions
New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune ResponseAugust 14th, 2024
Study Uncovers Key Parts of Mechanism for Activating T Cells to Fight Cancer and Other DiseasesOctober 30th, 2018
Cancer-Fighting T Cells Are Smarter, Stronger Than Experts ThoughtAugust 11th, 2017
Grant Support
- RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segmentDANA-FARBER CANCER INST2024–2029
- A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapiesDANA-FARBER CANCER INST2022–2027
- Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineageDANA-FARBER CANCER INST2020–2025
- Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineageDANA-FARBER CANCER INST2020–2025
- Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineageDANA-FARBER CANCER INST2020–2025
- Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineageDANA-FARBER CANCER INST2020–2025
- Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineageDANA-FARBER CANCER INST2020–2025
